We are harnessing the immune system to treat neurodegeneration and cancer.
Biotechnology • Neurodegenerative disease • Neurodegeneration • Immuno-neurology
51 - 200
💰 $133M Series E on 2018-07
4 days ago
🔄 Hybrid – San Francisco
⏳ Contract/Temporary
🔴 Lead
👷♀️ Project Manager
🛂 H1B Visa Sponsor
August 8
🟠 Senior
⚙️ Operations
July 24
🏢 In-office - San Francisco
⏰ Full Time
🏡 Remote – Anywhere in California
🟢 Junior
🟡 Mid-level
🔧 QA Engineer (Quality Assurance)
Google Cloud Platform
June 28
🧑⚖️ General Counsel